Sun Pharmaceuticals Industries consolidated net profit rises 10.51% in the September 2022 quarter
Sales rise 13.11% to Rs 10809.19 crore
Net profit of Sun Pharmaceuticals Industries rose 10.51% to Rs 2262.22 crore in the quarter ended September 2022 as against Rs 2047.01 crore during the previous quarter ended September 2021. Sales rose 13.11% to Rs 10809.19 crore in the quarter ended September 2022 as against Rs 9556.74 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales10809.199556.74 13 OPM %27.3527.52 -PBDT3022.382816.88 7 PBT2412.432286.51 6 NP2262.222047.01 11Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 01 2022 | 2:21 PM IST